Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85,635,017
-
Total 13F shares
-
13,625,016
-
Share change
-
+671,931
-
Total reported value
-
$206,745,000
-
Price per share
-
$15.17
-
Number of holders
-
37
-
Value change
-
+$10,358,995
-
Number of buys
-
17
-
Number of sells
-
10
Institutional Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q3 2020
As of 30 Sep 2020,
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,625,016 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., CHI Advisors LLC, ORBIMED ADVISORS LLC, ACUTA CAPITAL PARTNERS, LLC, Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Logos Global Management LP, Sio Capital Management, LLC, and Atlas Venture Advisors, Inc..
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.